Drugs / Dental pulp mesenchymal cell injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05127369 | Jan 2022 → Dec 2023 | depressive disorder | CAR-T (Shanghai) Biotechnology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dental pulp mesenchymal cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05127369 ↗ |
| Route | Intravenous | “administered intravenously on D1, D15 (2 weeks), D29 (4 weeks) and d43 (6 weeks)” NCT05127369 ↗ |